Anti-Human MAP Kinase-Activating Death Domain (CT) (MADD)

Home/Primary Monoclonal Antibodies/Apoptosis & Cell Biology/Anti-Human MAP Kinase-Activating Death Domain (CT) (MADD)

Pricing & Details

Product No.M1021
Protein
MADD
Formats AvailableView All
Product Type
Polyclonal Antibody
Alternate Names
DENN
Applications
IHC FFPE
,
WB
Prod No.
Size
Price
Avail.
Qty
Add to cart
M1021-20ug
20 µg
$195.00
In stock
Max:
Min: 1
Step: 1
M1021-0.1 mg
0.1 mg
$397.00
In stock
Max:
Min: 1
Step: 1
Bulk quantities available. Contact us for pricing.

Antibody Details

Product Details

Reactivity Species
Human
Host Species
Rabbit
Immunogen
PN:M1207
Product Concentration
0.5 mg/ml
Formulation
This polyclonal antibody is formulated in phosphate buffered saline (PBS) pH 7.4 containing 0.02% sodium azide as a preservative.
Storage and Handling
This polyclonal antibody is stable for at least one week when stored at 2-8°C. For long term storage, aliquot in working volumes without diluting and store at –20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
Country of Origin
USA
Shipping
Next Day Ambient
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.

Description

Specificity
Rabbit Anti-Human MAP Kinase-Activating Death Domain (MADD) recognizes Human, Mouse and Rat MADD. This polyclonal antibody was purified using affinity chromatography.
Background
MAP kinase-activating death domain protein (MADD) was initially identified as the type 1 tumor necrosis factor receptor (TNFR1) associated protein though their death domains. Overexpression of MADD activates MAP kinases ERK and JNK and induces the phosphorylation of cytosolic phospholipase A2. MADD shares 98% identity with DENN (for differentially expressed in neoplastic vs. normal cells), which was recently identified as a substrate for c-jun N-terminal kinase 3 (JNK3). MADD has greater than 94% overall identity to a GDP/GTP exchange protein Rab3-GEP. MADD is 87% identical to KIAA0358, a brain protein of unknown function. Identification of MADD as a component of the TNFR1 signaling complex and the similarity between MADD and Rab3-GEP provides a connection between TNFR1 activation and downstream MAP kinase activity through a guanine-nucleotide exchange protein.

Antigen Details

Protein
PubMed

References & Citations

1. Schievella, AR. et al. (1997) J. Biol. Chem. 272:12069
2. Chow, VT. et al. (1996) DNA Seq. 6:263
3. Zhang, Y. et al. (1998) Proc. Natl. Acad. Sci. USA 95:2586
4. Brown, TL. et al. (1998) Curr. Biol. 8:R191
IHC
General Western Blot Protocol
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Leinco Technologies uses cookies to improve your experience and our website service. By continuing to browse our website, you accept our cookie policy. Ok